Observational studyBMJ open respiratory research2023

Omalizumab for Chinese patients with moderate-to-severe allergic asthma in real-world clinical setting: a prospective, observational study.

Wen Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.